Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A Microbiota-Derived Metabolite Augments Cancer Immunotherapy Responses in Mice.

Literature DB >> 32976777

A Microbiota-Derived Metabolite Augments Cancer Immunotherapy Responses in Mice.

Abstract

Improving the rate of patient response to immune checkpoint blockade therapy is a current clinical goal. An article published in Science suggests that some members of the gut microbiome may provide a key molecule toward this end.

Entities: Disease Species

Year: 2020 PMID： 32976777 DOI： 10.1016/j.ccell.2020.09.005

Source DB: PubMed Journal: Cancer Cell ISSN： 1535-6108 Impact factor: 31.743

Keyword Cloud
Cited

7 in total

Review 1. Gut microbiome in gastrointestinal cancer: a friend or foe?

Authors: Yang Liu; Yoshifumi Baba; Takatsugu Ishimoto; Xi Gu; Jun Zhang; Daichi Nomoto; Kazuo Okadome; Hideo Baba; Peng Qiu
Journal: Int J Biol Sci Date: 2022-06-21 Impact factor: 10.750

Review 2. The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor?

Authors: Jiayao Ma; Lingjuan Huang; Die Hu; Shan Zeng; Ying Han; Hong Shen
Journal: J Exp Clin Cancer Res Date: 2021-10-16

3. Dynamic Alterations of the Gut Microbial Pyrimidine and Purine Metabolism in the Development of Liver Cirrhosis.

Authors: Yinghui Xiong; Li Wu; Li Shao; Yang Wang; Zebing Huang; Xun Huang; Chunhui Li; Anhua Wu; Zhenguo Liu; Xuegong Fan; Pengcheng Zhou
Journal: Front Mol Biosci Date: 2022-01-28

4. Lacticaseibacillus paracasei sh2020 induced antitumor immunity and synergized with anti-programmed cell death 1 to reduce tumor burden in mice.

Authors: Shi-Long Zhang; Bing Han; Yu-Qin Mao; Zheng-Yan Zhang; Zhan-Ming Li; Chao-Yue Kong; You Wu; Guo-Qiang Chen; Li-Shun Wang
Journal: Gut Microbes Date: 2022 Jan-Dec

A Microbiota-Derived Metabolite Augments Cancer Immunotherapy Responses in Mice.

Review 1. Gut microbiome in gastrointestinal cancer: a friend or foe?

Review 2. The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor?

3. Dynamic Alterations of the Gut Microbial Pyrimidine and Purine Metabolism in the Development of Liver Cirrhosis.

4. Lacticaseibacillus paracasei sh2020 induced antitumor immunity and synergized with anti-programmed cell death 1 to reduce tumor burden in mice.

Review 5. Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies.

Review 6. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.

Review 7. The Gut Microbiota in Inflammatory Bowel Disease.